The cytoprotective activity of GRP170 is also reflected in its elevation in certain cancer cells and resultant resistance of tumor cells to the induction of cell death, which supports a potential tumor-promoting role of GRP170 during cancer progression. This evidence concerns the gene HYOU1 and neoplasm.